Getting past PTSD

How Neurovation’s GRIA1 programs could improve PTSD diagnosis and treatment

Neurovation Labs Inc. is developing a GRIA1-targeting tracer and a small molecule therapy that could provide an objective diagnosis of PTSD and treat the underlying disease instead of just its symptoms.

Post-traumatic stress disorder (PTSD) is diagnosed with a symptom checklist that is typically self-reported and therefore not objective.

Approved treatments include behavioral psychotherapy and the generic serotonin reuptake inhibitor (SSRI)

Read the full 607 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE